Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cohesive Technologies was a specialized provider of advanced liquid chromatography and mass spectrometry solutions, most notably recognized for its proprietary TurboFlow technology. This technology revolutionized sample preparation by enabling the high-speed, automated extraction of drugs and metabolites directly from complex biological matrices like plasma and urine. By minimizing the need for manual sample cleanup, the company's systems significantly increased throughput and data quality for pharmaceutical and clinical laboratories. In 2006, the company was acquired by Thermo Fisher Scientific to bolster its chromatography and mass spectrometry portfolio. Today, its core technologies remain integrated into Thermo Fisher's high-end analytical instrumentation offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cohesive Technologies.